Compare Chewy Inc (CHWY) vs UiPath Inc (PATH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chewy Inc vs UiPath Inc — how do they compare? Chewy Inc trades at $22.48 (market cap $9.25B), while UiPath Inc trades at $15.65 (market cap $8.08B). The key difference: Chewy Inc and UiPath Inc are close in size by market cap, and UiPath Inc is trading nearer its 52-week high, Chewy Inc nearer its low. Which is the better fit depends on your goals.
| CHWY | PATH | |
|---|---|---|
Market Cap | $9.25B | $8.08B |
Sector | Consumer Cyclical | Technology |
52-Week High | $42.33 | $19.29 |
52-Week Low | $17.51 | $9.38 |
Enterprise Value | $9.21B | $6.85B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Chewy (CHWY) trades at $23.53, up 0.43% with a bullish technical signal supported by moving averages. The company shows strong revenue growth from $8.9B in 2022 to $11.86B in 2025, with net income turning positive at $393M. Recent earnings beat expectations in Q1 2026 with EPS of $0.43 versus $0.24 expected. Analyst consensus remains strongly bullish with 81.58% buy ratings and a $33.82 price target, representing 44% upside potential from current levels.
Chewy's outlook appears favorable with expanding veterinary services and Autoship subscription model driving recurring revenue. Key risks include competitive pressure from Amazon and Walmart, insider selling activity, and margin compression as net income margin is projected to decline to 1.98% in 2026. The stock offers growth potential but requires monitoring of execution against aggressive expansion plans.
UiPath (PATH) trades at $15.05, up 7.5% amid an AI stock rally, with technical indicators showing bullish momentum despite an overbought RSI. The company demonstrates strong revenue growth, improving from $892M in 2022 to $1.43B in 2025, with net income turning positive in 2026. Recent earnings show mixed results with Q1 2026 missing expectations, but Q3 and Q4 2025 beating estimates. Analyst sentiment remains cautious with a $13.33 consensus target below current price.
PATH offers exposure to enterprise automation growth with improving profitability, but faces execution risks and competitive pressures. The stock trades at premium valuations (P/E 25.08, P/S 4.86) while cash flow trends show improvement from negative $182M in 2025 to projected negative $67M in 2026. Key risks include AI competition and software spending volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chewy Inc
Chewy is the largest e-commerce pet care retailer in the U.S., generating $8.9 billion in 2021 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a standalone company in 2019, after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
Read more on CHWY →About UiPath Inc
UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →
